AstraZeneca to buy Canadian cancer specialist Fusion for $2.4bn
Posted: Wed Mar 20, 2024 12:19 am
AstraZeneca to buy Canadian cancer specialist Fusion for $2.4bn
Read more here:
https://www.theguardian.com/business/20 ... cer-fusion
Britain’s biggest drugmaker, AstraZeneca, is to buy a Canadian cancer specialist focused on next-generation treatments for $2.4bn (£1.9bn), the latest in a string of acquisitions made to strengthen its portfolio of new medicines.
The Anglo-Swedish company struck an agreement to acquire Fusion Pharmaceuticals, which is developing next-generation radioconjugates that offer an alternative to chemotherapy and radiotherapy. It has emerged as a new type of cancer treatment in recent years, and delivers a radioactive isotope directly to cancer cells through precise targeting using molecules such as antibodies, peptides or small molecules.
Compared with traditional radiotherapy, the new medicines minimise damage to healthy cells and enable access to tumours not reachable through external beam radiation. They are based on actinium, a radioactive element.
Read more here:
https://www.theguardian.com/business/20 ... cer-fusion
Britain’s biggest drugmaker, AstraZeneca, is to buy a Canadian cancer specialist focused on next-generation treatments for $2.4bn (£1.9bn), the latest in a string of acquisitions made to strengthen its portfolio of new medicines.
The Anglo-Swedish company struck an agreement to acquire Fusion Pharmaceuticals, which is developing next-generation radioconjugates that offer an alternative to chemotherapy and radiotherapy. It has emerged as a new type of cancer treatment in recent years, and delivers a radioactive isotope directly to cancer cells through precise targeting using molecules such as antibodies, peptides or small molecules.
Compared with traditional radiotherapy, the new medicines minimise damage to healthy cells and enable access to tumours not reachable through external beam radiation. They are based on actinium, a radioactive element.